STOCK TITAN

Ocugen (NASDAQ: OCGN) CFO assumes principal accounting role

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Ocugen, Inc. reports a leadership change in its finance function. Effective May 29, 2026, Ramesh Ramachandran resigned as Chief Accounting Officer, a role that also carried responsibility as principal accounting officer.

Following his resignation, on June 3, 2026, Chief Financial Officer Rita Johnson-Greene was appointed as principal accounting officer. Her employment terms and background were previously described in a Form 8-K filed on February 9, 2026. The company states there are no special arrangements behind her appointment, no family relationships with directors or executives, and no related-party transactions requiring disclosure.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
CAO resignation effective date May 29, 2026 Resignation of Chief Accounting Officer Ramesh Ramachandran
Principal accounting officer appointment date June 3, 2026 CFO Rita Johnson-Greene appointed principal accounting officer
Company phone number (484) 328-4701 Ocugen principal executive offices contact
principal accounting officer financial
"was appointed as the Company’s principal accounting officer"
The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Regulation S-K regulatory
"requiring disclosure under Item 404(a) of Regulation S-K"
A set of U.S. Securities and Exchange Commission rules that tell public companies which narrative and qualitative details must be disclosed in filings, such as risk factors, management discussion, executive pay, legal proceedings and business description. Think of it as a standardized checklist or blueprint that ensures investors get the same types of background information from every company so they can compare risks, management quality and strategy before making investment decisions.
Item 404(a) regulatory
"transactions involving Ms. Johnson-Greene requiring disclosure under Item 404(a)"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001372299 0001372299 2026-05-29 2026-05-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 29, 2026

 

OCUGEN, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-36751   04-3522315
(State or other jurisdiction
of incorporation)
  (Commission File
Number)
  (IRS Employer
Identification No.)

 

11 Great Valley Parkway

Malvern, Pennsylvania

  19355
(Address of principal executive offices)   (Zip Code)

 

(484) 328-4701

Registrant’s telephone number, including area code: 

 

N/A

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange
on which registered
Common Stock, par value $0.01 per share   OCGN  

The Nasdaq Stock Market LLC

(The Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective May 29, 2026, Ramesh Ramachandran, CPA, MBA, CMA, resigned as the Chief Accounting Officer of Ocugen, Inc. (the “Company”). Following the resignation of Mr. Ramachandran, who was designated as the Company's principal accounting officer prior to his resignation, on June 3, 2026, Rita Johnson-Greene, MBA, the Company’s Chief Financial Officer, was appointed as the Company’s principal accounting officer.

 

Descriptions of the material terms of Ms. Johnson-Greene’s employment agreement and Ms. Johnson-Greene’s biographical information were previously included in the Company’s Current Report on Form 8-K filed on February 9, 2026, which descriptions are incorporated herein by reference. There are no arrangements or understandings between Ms. Johnson-Greene and any other persons pursuant to which Ms. Johnson-Greene was appointed as principal accounting officer of the Company. In addition, there are no family relationships between Ms. Johnson-Greene and any director or executive officer of the Company, and there are no transactions involving Ms. Johnson-Greene requiring disclosure under Item 404(a) of Regulation S-K.

 

1 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    OCUGEN, INC.
     
Date: June 3, 2026 By: /s/ Shankar Musunuri
    Name: Shankar Musunuri
    Title: Chairman, Chief Executive Officer, & Co-Founder

 

2 

 

FAQ

What leadership change did Ocugen (OCGN) disclose in this Form 8-K?

Ocugen disclosed that Chief Accounting Officer Ramesh Ramachandran resigned effective May 29, 2026. The company then appointed its Chief Financial Officer, Rita Johnson-Greene, as principal accounting officer on June 3, 2026, consolidating key finance and accounting oversight roles under her.

Who is now Ocugen (OCGN)’s principal accounting officer?

Ocugen’s principal accounting officer is now Chief Financial Officer Rita Johnson-Greene. She was appointed to this role on June 3, 2026, after the resignation of former Chief Accounting Officer Ramesh Ramachandran, and her prior employment terms were previously described in a February 9, 2026 Form 8-K.

When did Ocugen (OCGN)’s Chief Accounting Officer resign?

Chief Accounting Officer Ramesh Ramachandran resigned effective May 29, 2026. This change removed him from the principal accounting officer role, prompting Ocugen to designate its existing Chief Financial Officer, Rita Johnson-Greene, as the new principal accounting officer several days later.

Does Ocugen (OCGN) report any special arrangements behind Rita Johnson-Greene’s appointment?

Ocugen states there are no arrangements or understandings with any persons under which Rita Johnson-Greene was appointed principal accounting officer. The filing emphasizes that her appointment is not tied to side agreements or special relationships beyond her existing position as Chief Financial Officer.

Where were Ocugen (OCGN)’s prior disclosures on Rita Johnson-Greene’s role provided?

Ocugen states that material terms of Rita Johnson-Greene’s employment agreement and her biographical information were previously included in a Form 8-K filed on February 9, 2026. Those prior disclosures are incorporated by reference into this leadership change report.

Filing Exhibits & Attachments

3 documents